Financhill
Sell
42

CYTK Quote, Financials, Valuation and Earnings

Last price:
$64.10
Seasonality move :
-5.29%
Day range:
$62.13 - $64.40
52-week range:
$29.31 - $70.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
86.23x
P/B ratio:
61.87x
Volume:
1.1M
Avg. volume:
2M
1-year change:
24.51%
Market cap:
$7.7B
Revenue:
$18.5M
EPS (TTM):
-$6.31

CYTK Analysts' Consensus Rating

The 13 analysts providing 12-month price projections for Cytokinetics, Inc. shares anticipate an average target of $89.44, ranging from a low estimate of $61.00 to a high estimate of $136.00. This average target implies a growth of 41.55% compared to the current stock price of $63.19.

Consensus Price Target

$89.44

Highest Price Target

$136.00

Lowest Price Target

$61.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 9 10 10

Hold 4 3 3

Sell 0 0 0
Consensus Buy Buy Buy

CYTK Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
52
CVLT alert for Jan 27

Commvault Systems, Inc. [CVLT] is down 29.45% over the past day.

Sell
47
AGYS alert for Jan 27

Agilysys, Inc. [AGYS] is down 20.3% over the past day.

Buy
71
GLSI alert for Jan 27

Greenwich LifeSciences, Inc. [GLSI] is up 1.8% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock